LEUNG GABRIEL

CIK 00012361835 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001236183

Recent Transactions

50 trades

Award
NovoCure Ltd$NVCR
Stock Option (Right to Buy)
2025-06-04+16,697→ 16,697 total
Award
NovoCure Ltd$NVCR
Ordinary Shares
2025-06-04+11,215→ 92,444 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2025-06-03$17.31/sh−999→ 81,229 total
Award
NovoCure Ltd$NVCR
Stock Option (Right to Buy)
2024-06-05+6,229→ 6,229 total
Award
NovoCure Ltd$NVCR
Restricted Stock Units
2024-06-05+4,053→ 83,192 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2024-06-04$23.89/sh−964→ 78,175 total
Award
NovoCure Ltd$NVCR
Stock Option (Right to Buy)
2023-06-07+6,277→ 6,277 total
Award
NovoCure Ltd$NVCR
Restricted Stock Units
2023-06-07+3,853→ 79,139 total
Award
NovoCure Ltd$NVCR
Restricted Stock Units
2022-06-08+2,427→ 75,286 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2022-06-08+4,350→ 4,350 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-08-05$152.50/sh−1,000→ 72,859 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-08-05$31.45/sh+1,000→ 73,859 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-08-05−1,000→ 2,345 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-07-06$183.54/sh−1,000→ 72,859 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-07-06−1,000→ 3,345 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-07-06$31.45/sh+1,000→ 73,859 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-06-09+1,499→ 1,499 total
Award
NovoCure Ltd$NVCR
Restricted Stock Units
2021-06-09+814→ 72,859 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-06-07$204.55/sh−1,000→ 72,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-06-07−1,000→ 4,345 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-06-07$31.45/sh+1,000→ 73,045 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-05-05$199.67/sh−1,000→ 72,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-05-05−1,000→ 5,345 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-05-05$31.45/sh+1,000→ 73,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$31.45/sh+6,000→ 78,045 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$198.01/sh−3,500→ 74,545 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$200.00/sh−2,500→ 72,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2021-04-13−6,000→ 6,345 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-15$7.48/sh+2,173→ 74,218 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-15$7.48/sh+7,392→ 79,437 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-15$100.00/sh−7,392→ 72,045 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-15$100.00/sh−2,173→ 72,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-09-15−7,392→ 0 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-09-15−2,173→ 0 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-14$7.48/sh+10,000→ 82,045 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-14$95.00/sh−10,000→ 72,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-09-14−10,000→ 2,173 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-09-10−10,000→ 12,173 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-10$90.00/sh−10,000→ 72,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-10$7.48/sh+10,000→ 82,045 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-09$85.39/sh−9,014→ 72,145 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-09-09−9,114→ 0 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-09$86.06/sh−100→ 72,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-09$7.03/sh+9,114→ 81,159 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-09-02−100→ 9,114 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-02$85.00/sh−100→ 72,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-09-02$7.03/sh+100→ 72,145 total
Exercise/Conversion
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2020-08-25−7,112→ 0 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-08-25$80.13/sh−7,112→ 72,045 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-08-25$7.03/sh+7,112→ 79,157 total

Companies

Recent Filings

Address

C/O OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD

NEW YORK, NY, 11747

View on SEC.gov